Enantioselective Reduction of Benzofuranyl Aryl Ketones

Abstract

Enantioselective transfer hydrogenation of benzofuranyl aryl ketones proceeds with moderate to good enantioselectivity even when the aryl group is not sterically differentiated by ortho-substituents. The best results are obtained with substrates that are functionalised by electron-withdrawing aryl groups that contrast with the electron-rich benzofuran, which is consistent with [Ru-ArC-H]˙Ar π interactions acting as a control element. Enantioselective pressure hydrogenation gives lower enantioselectivity irrespective of electronic effects, unless the aryl group is ortho-substituted, in which case up to 86% ee can be realised.

asymmetric transfer hydrogenation - asymmetric hydrogenation - heterocyclic ketones - asymmetric catalysis - electronic control

References and Notes

1a The comprehensive handbook of homogeneous hydrogenation   Elsevier CJ. DeVries JNH. Wiley-VCH; Weinheim: 2006. 

1b Ikariya T. Blacker AJ. Acc. Chem. Res.  2007,  40:  1300 

1c Gladiali S. Alberico E. Chem. Soc. Rev.  2006,  35:  226 

1d Hashiguchi S. Fujii A. Takehara J. Ikariya T. Noyori R. J. Am. Chem. Soc.  1995,  117:  7562 

1e Ohhuma T. Ooka H. Ikariya T. Noyori R. J. Am. Chem. Soc.  1995,  117:  10417 

1f Takehara J. Hashiguchi S. Fujii A. Inoue S.-I. Ikariya T. Noyori R. Chem. Commun.  1996,  233 

1g Blacker AJ, and Mellor BJ. inventors;  WO9842643A1. 

1h Doucet H. Ohkuma T. Murata K. Yokozawa T. Kazawa M. Katayama E. England AF. Ikariya T. Noyori R. Angew. Chem. Int. Ed.  1998,  37:  1703 

2a Noyori R. Ohkuma T. Angew. Chem. Int. Ed.  2001,  40:  40 

2b Lennon IC. Casy G. Johnson NB. Chem. Today  2003,  63 

2c Lennon IC. Moran PH. Curr. Opin. Drug Discovery Dev.  2003,  6:  855 

2d Lennon IC. Ramsden JA. Org. Process Res. Dev.  2005,  9:  110 

2e Diaz-Venezuela MB. Phillips SD. France MB. Gunn ME. Clarke ML. Chem. Eur. J.  2009,  15:  1227 

2f Chen C.-Y. Reamer R. Chilenski JR. McWilliams CJ. Org. Lett.  2003,  5:  5039 

2g Ohkuma T. Koizumi M. Yoshida M. Noyori R. Org. Lett.  2000,  2:  1749 

2h Morris DJ. Hayes AM. Wills M. J. Org. Chem.  2006,  71:  7035 

3a Wu X. Vinci D. Ikariya T. Xiao J. Chem. Commun.  2005,  447 

3b Zaidlewicz M. Tafelska-Kaczmarek A. Prewysz-Kwinto A. Tetrahedron: Asymmetry  2005,  16:  3205 

4a Nichols DE. Hoffman AJ. Oberlender RA. Riggs RM. J. Med. Chem.  1986,  29:  302 

4b Cho C.-H. Neuenswander B. Lushington GH. Larock RC.
J. Comb. Chem.  2008,  10:  941 ; and references therein

4c Nichols DE. Snyder SE. Oberlender R. Hohnson MP. Huang Z. J. Med. Chem.  1991,  34:  276 

4d Johansson G. Brisander N. Sundquist S. Hacksell U. Chirality  1998,  10:  813 

4e de Carvalho e Silveiria GP. Coelho F. Tetrahedron Lett.  2005,  46:  6477 

4f Sun L.-Q. Takaki K. Chen J. Bertenshaw S. Iben L. Mahle CD. Ryan E. Gao Q. Xu C. Bioorg. Med. Chem. Lett.  2005,  15:  1345 

4g Vinh TK. Lopez Delgado PO. Fernandez-Perez S. Walters HM. Smith HJ. Nichols PJ. Simons C. Bioorg. Med. Chem. Lett.  1999,  9:  2105 

5a Brandt P. Roth P. Andersson PG. J. Org. Chem.  2004,  69:  4885 

5b Ohhuma T. Koizumi M. Ikehira H. Yokozawa T. Noyori R. Org. Lett.  2000,  2:  659 

5c Sandoval CA. Qixun S. Liu S. Noyori R. Chem. Asian J.  2010,  4:  1221 

6 Maerten E. Agbossou-Niedercorn F. Castanet Y. Mortreux A. Tetrahedron  2008,  64:  8700 

7 Gill M. Tetrahedron  1984,  40:  621 

8 An almost identical R-configured alcohol to 13 (fluoro rather than chloro) gave opposite optical rotation to (S)-13, see: Botta M. Summa V. Corelli F. Di Pietro G. Lombardi P. Tetrahedron: Asymmetry  1996,  7:  1263 

9

The catalysts used were formed from either [RuCl₂(benzene)]₂, [RuCl₂(p-cymene)]₂ or [RhCl₂Cp*]₂ and (S,S)-Ts-DPEN or (1R,2S)-(+)-cis-1-amino-2-indanol. Using [RuCl₂(R)-BINAP(R,R)-DPEN], alcohol 16 was assigned as having R-configuration by Mosher analysis^6,8 on the mandelate ester (see the Supporting Information). A similar analysis was carried out on alcohol 15. The other alcohols, which show similar HPLC behaviour, are therefore proposed to have the (R)-configuration. Transfer hydrogenation reactions using [RuCl₂(benzene)]₂, [RuCl₂(p-cymene)]₂ or [RhCl₂Cp*]₂ combined with (S,S)-Ts-DPEN or (1R,2S)-(+)-cis-1-amino-2-indanol as catalyst, gave the opposite S-configured alcohols in each case.
2-(Trimethylsilyl)benzofuran:⁷ A solution of 2,3-benzo-furan (5.1 mL, 46 mmol) in anhydrous THF (50 mL) was cooled to -78 ˚C in a nitrogen atmosphere. n-BuLi (40 mL, 1.6 M in hexanes, 64 mmol) was then added slowly to the solution. After stirring at -78 ˚C for 1 h, chlorotri-methyl-silane (9.5 mL, 75 mmol) was added to the suspension. The mixture was then allowed to stir at -78 ˚C for 1 h, then at r.t. for a further 16 h. The reaction mixture was diluted with hexanes, filtered, and evacuated in vacuo to give a crude yellow oil (9.108 g). The crude product was purified by column chromatography (silica, hexane), to give a colourless oil (7.368 g, 39 mmol, 84%). ^¹H NMR (400 MHz, CDCl₃):
δ = 0.34 (s, 9 H, SiCH₃), 6.84 (s, 1 H, CHCSiMe₃), 7.13-7.29 (m, 2 H, 2 × ArH), 7.45-7.60 (s, 2 H, 2 × ArH); ^¹³C NMR (75 MHz, CDCl₃): δ = 0.1 [Si(CH₃)₃], 113.1 [CHC(SiMe₃)], 117.8 (ArCH), 122.8 (ArCH), 124.1 (ArCH), 126.1 (ArCH), 129.8 (ArC ipso-CH), 159.9 (CSiMe₃), 165.3 (ArC ipso-Oxygen); MS (ES+): m/z = 213.12 [M + Na]⁺.
Acylation of 2-(trimethylsilyl)benzofuran; General Procedure A: To a solution of an acid chloride (1.1 equiv) in anhydrous CH₂Cl₂ under a nitrogen atmosphere, trimethyl-silylbenzofuran (1.0 equiv) was added. The solution was stirred vigorously at r.t., whilst TiCl₄ (1.25 equiv) was added dropwise. The resulting suspension was stirred at r.t. for 48 h, followed by addition of water. The solution was extracted with Et₂O, dried, and concentrated in vaccuo to give the crude product. The crude product was purified by column chromatography (hexane-CH₂Cl₂).
Using general Procedure A: Using trimethylsilylbenzofuran (5.00 g, 26.3 mmol), 2-methoxy-benzoyl chloride (4.39 g, 28.5 mmol), and TiCl₄ (3.6 mL, 33.2 mmol) in CH₂Cl₂ (100 mL), ketone 10 was obtained as a pale-yellow oil (4.10 g, 17.4 mmol, 66%). ^¹H NMR (400 MHz, CDCl₃): δ = 2.43 (s, 3 H, CH₃), 7.26-7.33 (m, 4 H, 4 × ArH), 7.40-7.45 (m, 1 H, ArH), 7.46-7.51 (m, 1 H, ArH), 7.56 (m, 1 H, ArH), 7.62 (d, 1 H, ArH), 7.60-7.64 (m, 1 H, ArH), 7.66-7.69 (m, 1 H, ArH); ^¹³C NMR (75 MHz, CDCl₃): δ = 20.2 (CH₃), 113.2 (CHCC=O), 117.9 (ArCH), 123.9 (ArCH), 124.4 (ArCH), 125.7 (ArCH), 127.5 (ArC ipso-CH), 128.9 (ArCH), 129.0 (ArCH), 131.4 (ArCH), 131.7 (ArCH), 137.8 (ArC), 153.1 (OCC=O), 156.7 (ArC ipso-Oxygen), 187.4 (C=O); MS (ES+): m/z = 258.85 [M + Na]⁺; HRMS: m/z calcd. for C₁₆H₁₂O₂Na: 259.0735; found: 259.0732; IR: 3064, 1939, 1660, 1549,1445, 1328, 1219, 1186, 1114cm^-¹; Anal. Calcd for C₁₆H₁₂O₂: C, 81.34; H, 5.12. Found: C, 81.39; H, 5.05.
Transfer Hydrogenation; General Procedure B: Under a nitrogen atmosphere, the substrate, internal standard, 0.25 mol% metal complex, 0.5 mol% ligand and t-BuOK (1 M in t-BuOH) were transferred into a microwave vial and dissolved in anhydrous and degassed solvent (3 mL) and stirred for 2 min. The reaction was then heated and stirred for16 h. The vials were cooled and the crude reaction mixture was analysed by ^¹H NMR using tetraethylsilane as an internal standard to calculate the conversion into product. In some instances, the products were isolated using column chromatography, and the products were fully characterised.
Pressure Hydrogenation; General Procedure C: Under a nitrogen atmosphere, the substrate, internal standard, 0.25 mol% metal complex and 0.5 mol% ligand were transferred into a microwave vial and dissolved in anhydrous and degassed solvent (3 mL) and stirred for 2 min. The vials were then transferred to a steel autoclave and pressurised with H₂ gas. The reaction was then heated and stirred for 16 h. The autoclave was immersed in cold water and depressurised. The crude reaction mixture was then analysed by ^¹H NMR using tetraethylsilane as an internal standard to calculate the conversion into product.
( S )- o -Methylphenyl(benzofuran-2-yl)methanol (16): Using general procedure B with substrate (58.3 mg, 0.23 mmol), [RhCp*Cl₂]₂ (0.25 mol%), and aminoindanol (0.5 mol%), a yellow semi-solid was obtained (69 mg, 0.228 mmol, 99%, >99% conversion, 74% ee [determined by HPLC: OD-H (i-PrOH-hexane, 10:90; flow: 0.5 mL/min)]). Comparison of the HPLC behaviour of this compound to an analogous sample that had been treated with methoxyphenyl-acetic acid and analysed by NMR, showed this sample to have (S)-configuration. [α] _d ^²0 +28.2 (c = 2.2 g/100 mL, CHCl₃); ^¹H NMR (300 MHz, CDCl₃): δ = 2.28 (s, 3 H, CH₃), 2.42 (br s, 1 H, OH), 6.07 (s, 1 H, CHOH), 6.34 (s, 1 H, ArH), 7.08-7.24 (m, 5 H, 5 × ArH), 7.35-7.45 (m, 2 H, 2 × ArH), 7.46-7.53 (m, 1 H, ArH); ^¹³C NMR (75 MHz, CDCl₃): δ = 19.1 (CH₃), 67.5 (CHOH), 104.6 (ArCH), 111.5 (CHCC=O), 121.3 (ArCH), 122.7 (ArCH), 124.5 (ArCH), 126.3 (ArCH), 128.4 (ArC ipso-CH), 128.7 (ArCH), 130.9 (ArCH), 136.0 (ArC), 138.7 (ArC), 156.0 (OCC=O), 159.2 (ArC ipso-oxygen); MS (ES+): m/z = 260.77 [M + Na]⁺.
For full experimental details, spectroscopic and analytical data, along with a discussion on the assignment of the configurations, see the Supporting Information.